In October 2023, a labor-and-delivery registered nurse at a Waterloo, Iowa hospital pleaded guilty to three federal counts — including acquiring a controlled substance by fraud and adulteration of a drug with intent to defraud — after investigators confirmed she had systematically diverted fentanyl from the unit's Pyxis controlled-substance cabinet for her own personal use between January and late March 2022. To conceal the thefts, she refilled the emptied vials with saline and falsified Pyxis documentation to make every withdrawal appear legitimate, leaving at least fifty patients — women in active labor, recovering from cesarean sections, and late-term pregnant patients in acute pain — without the fentanyl their charts showed they had received. The scheme unraveled when the hospital's pharmacy and nursing teams conducted a routine controlled-substance audit and flagged irreconcilable discrepancies between Pyxis sign-out records and patient pain-control outcomes; the recovered vials were submitted for laboratory testing, and every one came back as saline. The results triggered a joint investigation by the DEA Office of Diversion Control and the FDA's Office of Criminal Investigations. Lab confirmation that the saline in the recovered vials matched directly to her Pyxis sign-outs across more than fifty patient records served as the smoking gun that closed the case. She was sentenced on March 27, 2024 to one year and one day in federal prison — the minimum threshold required to preserve the Bureau of Prisons' discretion over early release — along with supervised release conditions and the permanent loss of her nursing license. ––– Disclaimer: This video is a dramatization based on real events. Some visual content was created with artificial intelligence assistance. Some details have been fictionalized and all names have been changed to protect the privacy of those involved.